Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Tatsch

Showing results (41-50 of 139) with videos related to

Pageof 14
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 1998
Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patientsS Dresel, K Tatsch, I Dähne, et al.
Nuclear Medicine Communications|June 14, 2001
Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 yearsM Chouker, K Tatsch, R Linke, et al.
Nuclear Medicine Communications|December 1, 1995
Diagnostic approach in acute pulmonary embolism: perfusion scintigraphy versus spiral computed tomographyS Dresel, A Stäbler, J Scheidler, et al.
Neuroscience Letters|May 4, 2000
Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomographyK H Krause, S H Dresel, J Krause, et al.
Neuroradiology|March 25, 1999
Relative quantification of signal on T2-weighted images in the basal ganglia: limited value in differential diagnosis of patients with parkinsonismJ Schwarz, E Kraft, T Vogl, et al.
Acta Psychiatrica Scandinavica|October 1, 1994
D2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effectsJ Scherer, K Tatsch, J Schwarz, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1997
D2-dopamine-receptor occupancy during treatment with haloperidol decanoateJ Scherer, K Tatsch, M Albus, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 11, 1999
Scintigraphically assessed cardiac sympathetic dysinnervation in poorly controlled type 1 diabetes mellitus: one-year follow-up with improved metabolic controlD Muhr-Becker, M Weiss, K Tatsch, et al.
Biological Psychiatry|November 1, 1994
Striatal D2-dopamine receptor occupancy during treatment with typical and atypical neurolepticsJ Scherer, K Tatsch, J Schwarz, et al.
Der Radiologe|September 4, 2008
[Therapy response of liver tumors after selective internal radiation therapy]T F Jakobs, R T Hoffmann, K Tatsch, et al.
Pageof 14

Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 1998
Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patientsS Dresel, K Tatsch, I Dähne, et al.
Nuclear Medicine Communications|June 14, 2001
Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 yearsM Chouker, K Tatsch, R Linke, et al.
Nuclear Medicine Communications|December 1, 1995
Diagnostic approach in acute pulmonary embolism: perfusion scintigraphy versus spiral computed tomographyS Dresel, A Stäbler, J Scheidler, et al.
Neuroscience Letters|May 4, 2000
Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomographyK H Krause, S H Dresel, J Krause, et al.
Neuroradiology|March 25, 1999
Relative quantification of signal on T2-weighted images in the basal ganglia: limited value in differential diagnosis of patients with parkinsonismJ Schwarz, E Kraft, T Vogl, et al.
Acta Psychiatrica Scandinavica|October 1, 1994
D2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effectsJ Scherer, K Tatsch, J Schwarz, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1997
D2-dopamine-receptor occupancy during treatment with haloperidol decanoateJ Scherer, K Tatsch, M Albus, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 11, 1999
Scintigraphically assessed cardiac sympathetic dysinnervation in poorly controlled type 1 diabetes mellitus: one-year follow-up with improved metabolic controlD Muhr-Becker, M Weiss, K Tatsch, et al.
Biological Psychiatry|November 1, 1994
Striatal D2-dopamine receptor occupancy during treatment with typical and atypical neurolepticsJ Scherer, K Tatsch, J Schwarz, et al.
Der Radiologe|September 4, 2008
[Therapy response of liver tumors after selective internal radiation therapy]T F Jakobs, R T Hoffmann, K Tatsch, et al.
Pageof 14